跳至主要内容
临床试验/IRCT20121028011288N15
IRCT20121028011288N15招募中3 期

Effects of Lactobacillus rhamnosus supplementation on inflammatory and oxidative biomarkers, gut microbiota profile, gut metabolites and cardiac remodeling in patients with Myocardial Infarction (MI)

Tabriz University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
All

入选标准

  • Patients with Myocardial Infarction and successful precancerous intervention (PCI)
  • age range from 30-60 years
  • body mass index (BMI) higher than 25 kg/m2 will be included in the study.

排除标准

  • patient with chronic renal failure; hemodialysis
  • previous myocardial infraction
  • patients receiving immunosuppressive, anti-inflammatory and corticosteroid drugs;
  • history of supplementation with pre/pro/symbiotic or antioxidants during previous two months will not be included in the study.
  • with Being irritable bowel syndrome; Crohn's disease or ulcerative colitis
  • Heart failure (functionclass III and IV), Heart valve diseases
  • Subjects with diabetes

研究者

相似试验